Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novozymes A/S    NZYM B   DK0060336014

NOVOZYMES A/S (NZYM B)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
12/11/2017 12/12/2017 12/13/2017 12/14/2017 12/15/2017 Date
341.3(c) 343(c) 343.6(c) 345.9(c) 344.2 Last
384 278 303 182 332 421 413 532 227 378 Volume
0.00% +0.50% +0.17% +0.67% -0.49% Change
More quotes
Financials ( DKK)
Sales 2017 14 621 M
EBIT 2017 4 125 M
Net income 2017 3 174 M
Debt 2017 1 939 M
Yield 2017 1,22%
Sales 2018 15 152 M
EBIT 2018 4 310 M
Net income 2018 3 334 M
Debt 2018 2 260 M
Yield 2018 1,33%
P/E ratio 2017 32,40
P/E ratio 2018 30,30
EV / Sales2017 6,08x
EV / Sales2018 5,89x
Capitalization 86 910 M
More Financials
Company
Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms.Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile, and wastewater solutions.The... 
Sector
Commodity Chemicals
Calendar
02/07Earnings Release
More about the company
Surperformance© ratings of Novozymes A/S
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVOZYMES A/S
12/07 NOVOZYMES A/S : Patent Application Titled "Enzyme Granules" Published Online (US..
11/30 NOVOZYMES A/S : Patent Issued for Nucleic Acids Encoding Arabinofuranosidase (US..
11/29 NOVOZYMES A/S : Trading by management and of close relations to management
11/21 NOVOZYMES A/S : ECHS students explore biotechnology
11/10 TRANSACTIONS UNDER NOVOZYMES’ : Novozymes has now completed the announced..
11/09 NOVOZYMES A/S : "Polypeptides Having Dextranase Activity and Polynucleotides Enc..
11/06 TRANSACTIONS UNDER NOVOZYMES’ : As of November 3, Novozymes has purchased..
10/30 TRANSACTIONS UNDER NOVOZYMES’ : As of October 27, Novozymes has purchased..
10/25 Eyes on European earnings, as Kering shares jump on sales surge
10/25 INTERIM REPORT FOR THE FIRST NINE MO : Solid first nine months with strong growt..
More news
Sector news : Commodity Chemicals - NEC
12/12 German domestic demand for factory equipment seen rising
12/12 Germany's VDMA sees UK engineering market stagnating under Brexit
12/12DJLanxess CEO Expresses Interest in Acquiring Akzo Chemicals -Bloomberg
12/06 Investors wean themselves off oil as electric future beckons
12/01 Axalta ends Nippon Paint talks after rejecting $9.1 billion bid
More sector news : Commodity Chemicals - NEC
News from SeekingAlpha
10/26 NOVO NORDISK : U.S. Obesity Epidemic To Provide Forward Growth Engine
10/25 Novozymes' (NVZMF) CEO Peder Holk Nielsen on Q3 2017 Results - Earnings Call ..
10/25 Novozymes A/S reports Q3 results
09/18 Nordic Dividend Royals
08/11 Novozymes' (NVZMF) CEO Peder Holk Nielsen on Q2 2017 Results - Earnings Call ..
Chart NOVOZYMES A/S
Duration : Period :
Novozymes A/S Technical Analysis Chart | NZYM B | DK0060336014 | 4-Traders
Technical analysis trends NOVOZYMES A/S
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Average target price 310  DKK
Spread / Average Target -10%
EPS Revisions
Managers
NameTitle
Peder Holk Nielsen President & Chief Executive Officer
Jørgen Buhl Rasmussen Chairman
Thomas Videbaek COO, Executive VP-Research, Innovation & Supply
Carl Erik Mathias Uhlén Independent Director
Lars Bo Køppler Director
Sector and Competitors
1st jan.Capitalization (M$)
NOVOZYMES A/S42.05%13 757
AIR LIQUIDE12.55%54 021
SHIN-ETSU CHEMICAL CO LTD26.78%44 266
PRAXAIR, INC.28.82%42 700
LYONDELLBASELL INDUSTRIES NV24.90%41 588
GIVAUDAN19.67%20 858